Form 8-K - Current report:
SEC Accession No. 0001641172-25-008331
Filing Date
2025-05-02
Accepted
2025-05-02 16:05:14
Documents
13
Period of Report
2025-05-02
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 29152
  Complete submission text file 0001641172-25-008331.txt   202426

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aztr-20250502.xsd EX-101.SCH 3018
3 XBRL LABEL FILE aztr-20250502_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE aztr-20250502_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 25908405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)